As one of the world's leading research universities, Harvard has a special obligation to advance science and medicine, foster innovation and promote the development of translational research and collaborations with industry. To this end, we make available from time to time information related to funding opportunities for Harvard investigators interested in exploring the potential of research collaborations with industry, and in developing nascent technologies originating in their labs. Although funding programs typically have a distinct focus and identity, they share the common goal of seeking to help Harvard faculty to progress and support their research in ways that may not be otherwise possible.
We encourage you and your colleagues across Harvard’s research community to take full advantage of the innovative funding opportunities that we hope will give rise to fertile new research collaborations. We look forward to your active engagement and participation.
Please review the information below to see more details on the current funding opportunities and Requests for Proposals (RFPs) available through Harvard’s Office of Technology Development. In the meantime, should you have any questions, please don’t hesitate to contact members of the OTD team.
Current Calls For Proposals
It is our pleasure to announce the following funding opportunity for Harvard investigators.
|Name of Program||Program Area(s)||Deadline||Guidelines||Contact|
|Physical Sciences and Engineering Accelerator||See Guidelines for more details||August 15, email@example.com|
Active Programs and Future Calls
Below are programs for which the latest request-for-proposal deadlines have passed. However, please be sure to check back from time to time for future rounds of funding in the Current Calls For Proposals section, above.
Hold your cursor over the underlined text to see further details of the programs, or download the respective Guidelines.
|Name of Program||Program Area(s)||Last Deadline||Guidelines||Contact|
|Blavatnik Biomedical Accelerator||Applied Life Science Research||Jan 27, firstname.lastname@example.org|
|Pfizer Centers for Therapeutic Innovation (CTI) Program||Multiple>||Ongoingemail@example.com|
|Roche Sponsored Research Program||Multiple>||Ongoingfirstname.lastname@example.org|